Breaking News Instant updates and real-time market news.

ZAYO

Zayo Group

$29.42

-0.02 (-0.07%)

10:37
04/10/19
04/10
10:37
04/10/19
10:37

Consortium in exclusive talks to acquire Zayo Group, Reuters reports

A consortium including Digital Colony Partners, EQT AB and Stonepeak Infrastructure Partners has secured exclusive rights to negotiate a deal to buy Zayo Group Holdings, Reuters reports, citing people familiar with the matter. After rejecting multiple offers from private equity bidders, Zayo agreed to negotiate with the consortium exclusively after it received an offer it deemed attractive enough, sources told Reuters. While the exact offer could not be learned, sources said it would value Zayo at between $8B and $9B, excluding $5.9B in long-term debt. A deal could be announced later this month, Reuters adds. Shares of Zayo Group are up 6%, or $1.74, to $31.19 following the report. Reference Link

  • 09

    May

ZAYO Zayo Group
$29.42

-0.02 (-0.07%)

02/04/19
COWN
02/04/19
NO CHANGE
Target $37
COWN
Outperform
Cowen believes Zayo Group deal is still likely in near-term
Cowen analyst Colby Synesael thinks Zayo Group and the previously reported private equity consortium have been unable to agree on a price so far, but he still thinks a deal is likely in the short-term. He expects Zayo to report downside for Q2 but he thinks booking will be good and that is the metric that will be focused on. Synesael maintained his Outperform rating and $37 price target on Zayo Group shares.
02/08/19
MSCO
02/08/19
NO CHANGE
Target $34
MSCO
Overweight
Zayo Group quarterly results a 'secondary focus' once again, says Morgan Stanley
Morgan Stanley analyst Simon Flannery said Zayo Group reported a nice rebound from last quarter's results and provided some encouraging data on the organic growth outlook with solid guidance for calendar 2019. However, "the quarterly results became a secondary focus of investors" once again as the company announced new plans to resegment the business into Network, zColo and Allstream, which makes it seem to him that the original plans to split into two public companies is now off the table for 2019. Additionally, Flannery quoted the company's CEO as stating that Zayo "is fully committed to considering alternatives that would maximize the value of our company. Investors should be confident that our board would engage with any party that makes a credible proposal that appropriately values the company." Flannery, who appreciates the improved results but thinks consistency "will be the ultimate determinant of the stock's performance," keeps an Overweight rating on Zayo shares.
02/11/19
DBAB
02/11/19
NO CHANGE
Target $31
DBAB
Buy
Zayo Group remains a preferred idea at Deutsche Bank
Deutsche Bank analyst Matthew Niknam says Zayo Group remains one of his preferred ideas. The analyst raised his price target for the shares to $31 from $30 and keeps a Buy rating on the name. Zayo has a "unique asset mix" as the largest independent owner of high-quality fiber in the U.S., Niknam tells investors in a research note. He believes this positions the company "in the sweet spot of Communications Infrastructure spending trends in upcoming years, as bandwidth needs rise from key verticals."
03/18/19
MSCO
03/18/19
NO CHANGE
Target $34
MSCO
Overweight
Zayo Group shares can continue to rally, says Morgan Stanley
Morgan Stanley analyst Simon Flannery noted that Zayo Group shares have rallied since the company postponed its March 14 analyst meeting as it evaluates strategic alternatives, but he sees several catalysts that should provide support for the stock over the coming months, including private equity interest, shareholder activism, a REIT response from the IRS and a potential Colocation/Allstream separation. He maintains an Overweight rating and $34 price target on Zayo Group shares.

TODAY'S FREE FLY STORIES

NVS

Novartis

$75.84

0.42 (0.56%)

05:38
04/24/19
04/24
05:38
04/24/19
05:38
Earnings
Novartis raises FY19 core operating income view to high single-digit growth »

Expects FY19 revenue to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 04

    May

  • 08

    May

  • 22

    May

  • 31

    May

NVS

Novartis

$75.84

0.42 (0.56%)

05:36
04/24/19
04/24
05:36
04/24/19
05:36
Earnings
Novartis reports Q1 core EPS $1.21, consensus $1.20 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 04

    May

  • 08

    May

  • 22

    May

  • 31

    May

VBIV

VBI Vaccines

$2.00

0.05 (2.56%)

05:34
04/24/19
04/24
05:34
04/24/19
05:34
Conference/Events
VBI Vaccines to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 23

    May

PLCE

Children's Place

$109.92

2.95 (2.76%)

05:34
04/24/19
04/24
05:34
04/24/19
05:34
Initiation
Children's Place initiated  »

Children's Place…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TAC

TransAlta

$6.88

-0.175 (-2.48%)

05:32
04/24/19
04/24
05:32
04/24/19
05:32
Hot Stocks
TransAlta comments on Mangrove Partners release, urges holders to vote BLUE card »

TransAlta commented on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

CRI

Carter's

$105.13

2.02 (1.96%)

05:31
04/24/19
04/24
05:31
04/24/19
05:31
Initiation
Carter's initiated  »

Carter's initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 16

    May

STRL

Sterling Construction

$13.77

0.19 (1.40%)

05:30
04/24/19
04/24
05:30
04/24/19
05:30
Hot Stocks
Sterling Construction awarded $23M contract by UDOT »

Sterling Construction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 08

    May

COST

Costco

$245.56

2.1 (0.86%)

05:27
04/24/19
04/24
05:27
04/24/19
05:27
Recommendations
Costco analyst commentary at Baird »

Costco price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 30

    May

EBAY

eBay

$36.66

0.51 (1.41%)

05:22
04/24/19
04/24
05:22
04/24/19
05:22
Recommendations
eBay analyst commentary  »

eBay price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABMD

Abiomed

$262.32

1.39 (0.53%)

05:19
04/24/19
04/24
05:19
04/24/19
05:19
Recommendations
Abiomed analyst commentary at Piper Jaffray »

CMS proposed rate changes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 05

    Jun

  • 13

    Nov

MMSI

Merit Medical

$59.13

1.57 (2.73%)

05:16
04/24/19
04/24
05:16
04/24/19
05:16
Recommendations
Merit Medical analyst commentary at Piper Jaffray »

Piper calls Merit Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 08

    May

  • 23

    May

HOLX

Hologic

$44.26

1.26 (2.93%)

05:13
04/24/19
04/24
05:13
04/24/19
05:13
Recommendations
Hologic analyst commentary at Piper Jaffray »

Hologic checks suggest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 03

    May

  • 07

    May

  • 29

    May

  • 05

    Jun

SYK

Stryker

$186.95

4.905 (2.69%)

05:09
04/24/19
04/24
05:09
04/24/19
05:09
Recommendations
Stryker analyst commentary at Piper Jaffray »

Stryker's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 08

    May

  • 29

    May

ICLK

iClick Interactive Asia

$3.89

-0.115 (-2.87%)

05:08
04/24/19
04/24
05:08
04/24/19
05:08
Hot Stocks
iClick enters marketing technology joint venture with VGI »

VGI Global Media and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBAY

eBay

$36.66

0.51 (1.41%)

05:05
04/24/19
04/24
05:05
04/24/19
05:05
Recommendations
eBay analyst commentary  »

eBay price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$38.92

-0.79 (-1.99%)

05:03
04/24/19
04/24
05:03
04/24/19
05:03
Downgrade
Harley-Davidson rating change  »

Harley-Davidson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

BBY

Best Buy

$73.60

1 (1.38%)

05:02
04/24/19
04/24
05:02
04/24/19
05:02
Upgrade
Best Buy rating change at Jefferies »

Best Buy upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

FOJCY

Fortum

$0.00

(0.00%)

05:00
04/24/19
04/24
05:00
04/24/19
05:00
Upgrade
Fortum rating change  »

Fortum upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGLOY

Anglo American

$0.00

(0.00%)

04:58
04/24/19
04/24
04:58
04/24/19
04:58
Downgrade
Anglo American rating change  »

Anglo American downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$11.99

0.46 (3.99%)

04:55
04/24/19
04/24
04:55
04/24/19
04:55
Upgrade
Snap rating change at JPMorgan »

Snap upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PIRS

Pieris Pharmaceuticals

$2.93

0.01 (0.34%)

04:55
04/24/19
04/24
04:55
04/24/19
04:55
Conference/Events
Pieris Pharmaceuticals management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 07

    May

MPSYF

Morphosys AG

$0.00

(0.00%)

04:55
04/24/19
04/24
04:55
04/24/19
04:55
Conference/Events
Morphosys AG management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

MOR

MorphoSys

$24.78

0.7 (2.91%)

04:55
04/24/19
04/24
04:55
04/24/19
04:55
Conference/Events
MorphoSys management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 08

    May

  • 20

    Jun

NTGN

Neon Therapeutics

$6.21

0.03 (0.49%)

04:55
04/24/19
04/24
04:55
04/24/19
04:55
Conference/Events
Neon Therapeutics management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

AXU

Alexco Resource

$0.96

-0.0396 (-3.98%)

04:55
04/24/19
04/24
04:55
04/24/19
04:55
Conference/Events
Alexco Resource management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 01

    May

  • 02

    May

  • 03

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.